Role of Melanocortin Receptors in the Regulation of Gouty Inflammation
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Melanocortin Receptors in the Regulation of Gouty Inflammation
Authors
Keywords
-
Journal
Current Rheumatology Reports
Volume 13, Issue 2, Pages 138-145
Publisher
Springer Nature
Online
2011-01-17
DOI
10.1007/s11926-011-0163-0
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Melanocortin Peptide Therapy for the Treatment of Arthritic Pathologies
- (2011) S. J. Getting et al. TheScientificWorldJOURNAL
- High versus low dosing of oral colchicine for early acute gout flare: Twenty-four-hour outcome of the first multicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colchicine study
- (2010) Robert A. Terkeltaub et al. ARTHRITIS AND RHEUMATISM
- Markedly reduced toxicity of a hydrogen sulphide-releasing derivative of naproxen (ATB-346)
- (2010) John L Wallace et al. BRITISH JOURNAL OF PHARMACOLOGY
- Anti-inflammatory and antiosteoclastogenesis properties of endogenous melanocortin receptor type 3 in experimental arthritis
- (2010) Hetal B. Patel et al. FASEB JOURNAL
- Update on gout: new therapeutic strategies and options
- (2010) Robert Terkeltaub Nature Reviews Rheumatology
- Hyperalgesia, synovitis and multiple biomarkers of inflammation are suppressed by interleukin 1 inhibition in a novel animal model of gouty arthritis
- (2009) R Torres et al. ANNALS OF THE RHEUMATIC DISEASES
- The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
- (2009) R Terkeltaub et al. ANNALS OF THE RHEUMATIC DISEASES
- The melanocortin system in articular chondrocytes: Melanocortin receptors, pro-opiomelanocortin, precursor proteases, and a regulatory effect of α-melanocyte-stimulating hormone on proinflammatory cytokines and extracellular matrix components
- (2009) Susanne Grässel et al. ARTHRITIS AND RHEUMATISM
- Monosodium urate crystals in inflammation and immunity
- (2009) Yan Shi et al. IMMUNOLOGICAL REVIEWS
- Intracellular innate immunity in gouty arthritis: role of NALP3 inflammasome
- (2009) Ru Liu-Bryan IMMUNOLOGY AND CELL BIOLOGY
- Cyclooxygenase-inhibiting nitric oxide donators for osteoarthritis
- (2009) John L. Wallace et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Melanocortin peptides inhibit urate crystal-induced activation of phagocytic cells
- (2009) Franco Capsoni et al. ARTHRITIS RESEARCH & THERAPY
- Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: A 28-week, phase III, randomized, double-blind, parallel-group trial
- (2008) H. RALPH Schumacher et al. ARTHRITIS AND RHEUMATISM
- Overview of the Management of Acute Gout and the Role of Adrenocorticotropic Hormone
- (2008) Naomi Schlesinger DRUGS
- α-Melanocyte-Stimulating Hormone and Related Tripeptides: Biochemistry, Antiinflammatory and Protective Effectsin Vitroandin Vivo, and Future Perspectives for the Treatment of Immune-Mediated Inflammatory Diseases
- (2008) Thomas Brzoska et al. ENDOCRINE REVIEWS
- Inflamed phenotype of the mesenteric microcirculation of melanocortin type 3 receptor-null mice after ischemia-reperfusion
- (2008) Giovanna Leoni et al. FASEB JOURNAL
- Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
- (2008) Hein JEM Janssens et al. LANCET
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started